These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29033841)

  • 41. Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Jan; 50(1):243-9. PubMed ID: 16377693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model.
    Katsube T; Yamano Y; Yano Y
    J Pharm Sci; 2008 Apr; 97(4):1606-14. PubMed ID: 17705288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kill Rate and Evaluation of
    Zhang L; Xie H; Wang H; Ding H; Zhang G; Hu J
    Front Vet Sci; 2021; 8():751957. PubMed ID: 34966804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models.
    Jiao J; Mao R; Teng D; Wang X; Hao Y; Yang N; Wang X; Feng X; Wang J
    AMB Express; 2017 Dec; 7(1):44. PubMed ID: 28220445
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Zhang W; Lu Y; Ma M; Yang J; Huang H; Peng X; Zeng Z; Zeng D
    Front Vet Sci; 2024; 11():1362292. PubMed ID: 38756506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.
    Lepak AJ; Parhi A; Madison M; Marchillo K; VanHecker J; Andes DR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6568-74. PubMed ID: 26259789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PK-PD integration and modeling of marbofloxacin in sheep.
    Sidhu PK; Landoni MF; Aliabadi FS; Lees P
    Res Vet Sci; 2010 Feb; 88(1):134-41. PubMed ID: 19523661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and Pharmacodynamics of Tildipirosin Against
    Zeng D; Sun M; Lin Z; Li M; Gehring R; Zeng Z
    Front Microbiol; 2018; 9():1038. PubMed ID: 29867911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
    Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
    J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation.
    Rubio-Langre S; Aguilar-Sola S; Lorenzutti AM; San Andrés MI; De Lucas JJ; Litterio NJ
    J Vet Pharmacol Ther; 2018 Dec; 41(6):861-870. PubMed ID: 30020535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
    Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
    Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
    Zobell JT; Stockmann C; Young DC; Cash J; McDowell BJ; Korgenski K; Sherwin CM; Spigarelli M; Chatfield BA; Ampofo K
    Clin Ther; 2011 Nov; 33(11):1844-50. PubMed ID: 22018680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concentration-Dependent Activity of Pazufloxacin against
    Umezaki Y; Matsumoto K; Ikawa K; Yokoyama Y; Enoki Y; Shigemi A; Watanabe E; Nakamura K; Ueno K; Terazono H; Morikawa N; Takeda Y
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary.
    Zhanel GG; Johanson C; Laing N; Hisanaga T; Wierzbowski A; Hoban DJ
    Antimicrob Agents Chemother; 2005 May; 49(5):1943-8. PubMed ID: 15855517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Nakamura R; Ito-Horiyama T; Takemura M; Toba S; Matsumoto S; Ikehara T; Tsuji M; Sato T; Yamano Y
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model.
    Zelenitsky SA; Ariano RE; Iacovides H; Sun S; Harding GK
    J Antimicrob Chemother; 2003 Apr; 51(4):905-11. PubMed ID: 12654762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How can we predict bacterial eradication?
    Jacobs MR
    Int J Infect Dis; 2003 Mar; 7 Suppl 1():S13-20. PubMed ID: 12839703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.